GC Aesthetics® your lifetime partner
Delivering high-quality products that empower patients to feel confident and safe in their breast enhancement journey.
Incorportated in United Kingdom
Incorporated in France
Aquires Eurosilicone & Nagor
Launch with the 6th Generation Gel
Evolves towards a Solution Provider
Implements an innovation Roadmap Strategy
Launches NOA™, Eve 4.0™ & published the 10-years Clinical Study
Launches PERLE™, HydroCone™ & GCA Comfort Plus™ Warranty
Eurosilicone™ & Nagor™ brands are transitioning to GCA® on all levels
Launches FixNip™ NRI
Launches Luna XT™
Launches of Puregraft® & Healena™
The GCA® Difference
More than 3 million breast implants placed in the last 10 years, supported by published 10-year clinical data demonstrating compelling safety and effectiveness in aesthetic and reconstructive breast surgery.
Our round and anatomical silicone gel breast implants are backed by long-term peer-reviewed studies evaluating safety, patient satisfaction, and revision rates.
Published clinical evidence includes:
- Ten-Year Safety Data for Eurosilicone’s Round and Anatomical Silicone Gel Breast Implants (Aesthetic Surgery Journal Open Forum, 2019)
- Single-Center and Surgeon’s Long-Term (15–19 Years) Patient Satisfaction and Revision Rate of Round Textured Eurosilicone Breast Implants (Aesthetic Surgery Journal, 2021)
This long-term follow-up reinforces our commitment to reliable breast implant performance and evidence-based medical device development.
To design, develop, manufacture, market, and offer best-in-class medical aesthetic solutions that contribute to women’s healthcare, well-being, confidence, empowerment, and overall happiness through safe, reliable breast implant devices placed in the hands of trained and qualified surgeons.
We are committed to advancing standards in breast augmentation and breast reconstruction by combining:
- Clinical research
- Rigorous manufacturing processes
- Regulatory compliance
- Continuous product innovation
To be the partner of choice for women and surgeons around the world, leading in science, reliability, and innovation in breast implant technology and medical aesthetic solutions.
We aim to continuously support the global surgical community by delivering:
- Proven long-term safety data
- Reliable silicone gel implant technology
- Ongoing scientific collaboration
- Responsible and transparent medical innovation
Through our Total Breast Care™ approach, we go beyond devices to support the full surgical journey, from consultation to long-term follow-up, helping surgeons improve patient compliance, optimize outcomes, and expand possibilities in both aesthetic and reconstructive procedures. By integrating solutions across pre-, intra-, and post-surgery, we enable more personalized treatments and support enhancement and hybrid procedures with greater confidence.
GC Aesthetics® News
GC Aesthetics® at the London Breast Meeting 2026: Advancing Modern Breast Augmentation
Read moreFive-Year Clinical Study Confirms the Strong Safety and Performance Profile of PERLE™ Breast Implants
Read moreGC Aesthetics® at the 58th National SECPRE Congress 2026: Advancing innovation and education in breast surgery
Read moreGC Aesthetics® at SOFCEP 2026: Supporting Innovation and Excellence in Aesthetic Surgery
Read moreGC Aesthetics® at FILACP 2026: Advancing Evidence-Based Breast Surgery in Latin America
Read moreGC Aesthetics® at IBSD 2026: Advancing Breast Surgery Through Innovation and Education
Read moreGC Aesthetics® at AMCPER 2026: Sponsored Symposium and Launch of Luna XT™ and PERLE™ in Mexico
Read moreGC Aesthetics® at Barcelona Breast Meeting 2026 | Platinum Sponsor & Scientific Contribution
Read moreFunnel-Assisted Breast Implant Insertion with Hyaluronic Acid: Clinical Evidence Supporting the No-Touch Technique
Read moreGC Aesthetics® at London Breast Meeting 2025: Elevating Aesthetic & Reconstructive Breast Surgery
Read moreImportant information
This form is for reporting complaints, product quality issues, or suspected adverse events relating to GC Aesthetics Products. Completing this form does not replace your legal rights or obligation to report a suspected incident directly to your healthcare provider. If you or the patient is experiencing a medical emergency or requires urgent medical attention, please contact emergency services or your treating clinician immediately rather than using this form.
Information you provide will be used by GC Aesthetics to investigate the complaint and, where required, to assess and fulfil its post-market surveillance and vigilance reporting obligations under applicable medical device legislation (including, as relevant, Regulation (EU) 2017/745 and the UK Medical Devices Regulations 2002, as amended). This may involve sharing relevant details with regulators, notified bodies, or competent authorities, as legally required. Please ensure the information provided is accurate and complete to the best of your knowledge. Submission of this form does not constitute an admission of liability or fault by GC Aesthetics, and GC Aesthetics' investigation of a complaint does not guarantee any particular outcome, remedy, or compensation.
Personal data submitted through this form will be processed in accordance with GC Aesthetics' Privacy Notice, available below https://www.gcaesthetics.com/patient-privacy-notice. GC Aesthetics aims to acknowledge receipt of complaints within 21 business days, though investigation timeframes will vary depending on complexity.
1. Duteille F, et al. Ten-Year Safety Data for Eurosilicone’s Round and Anatomical Silicone Gel Breast Implants. Aesthet Surg J Open Forum. 2019;1(2):ojz012. Published 2019 Apr 27.

